Classification, diagnosis, and management of cholangiocarcinoma
about
Hepatolithiasis and intrahepatic cholangiocarcinoma: A review.Hepatobiliary Tumors: Update on Diagnosis and ManagementCancer review: CholangiocarcinomaCholangiocarcinomaReview of endoscopic radiofrequency in biliopancreatic tumours with emphasis on clinical benefits, controversies and safetyUpdate on the Diagnosis and Treatment of Cholangiocarcinoma.IgG4-Associated Cholangitis Can Mimic Hilar Cholangiocarcinoma.Liver masses: a clinical, radiologic, and pathologic perspective.Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis.Angiopoietin-2 and biliary diseases: elevated serum, but not bile levels are associated with cholangiocarcinoma.Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation.Molecular pathogenesis of cholangiocarcinoma.Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2.Recent advances in the development of farnesoid X receptor agonistsPathogenesis, diagnosis, and management of cholangiocarcinomaSchistosome and liver fluke derived catechol-estrogens and helminth associated cancersInfection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome.Imaging of malignancies of the biliary tract- an update.A new clinically based staging system for perihilar cholangiocarcinoma.Cohort profile: cholangiocarcinoma screening and care program (CASCAP).Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinomaLiver cancer oncogenomics: opportunities and dilemmas for clinical applications.Hypoxia enhances cholangiocarcinoma invasion through activation of hepatocyte growth factor receptor and the extracellular signal‑regulated kinase signaling pathway.The Cholangiopathies.Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?Incidence of subsequent cholangiocarcinomas after another malignancy: trends in a population-based study.Expression of Molecular Differentiation Markers Does Not Correlate with Histological Differentiation Grade in Intrahepatic Cholangiocarcinoma.Why does infection with some helminths cause cancer?Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.New insights into the molecular pathogenesis of intrahepatic cholangiocarcinomaA perspective on molecular therapy in cholangiocarcinoma: present status and future directions.Improving the accuracy of pancreatobiliary tract cytology with fluorescence in situ hybridization: a molecular test with proven clinical success.Imaging bile duct tumors: staging.Endoscopic treatment options for cholangiocarcinomas.FISHing for pancreatobiliary tract malignancy in endoscopic brushings enhances the sensitivity of routine cytology.Molecular pathogenesis of intrahepatic cholangiocarcinoma.Surgical treatment of intrahepatic cholangiocarcinoma in the USA.The diagnosis and treatment of cholangiocarcinomaRole of the fibroblast growth factor receptor axis in cholangiocarcinoma.Cholangiocarcinoma: from molecular biology to treatment.
P2860
Q26771199-D8D339CA-9344-4484-8A57-48A020CF381FQ26775654-EE193EFF-B36D-4527-AB3F-57BFABC15EF5Q26865200-CEB3096C-4B97-4188-82FF-81AEE4B60B9BQ27001694-916B7A1A-F352-459B-823A-209FEE4962EDQ28077731-3C1AF4F8-0C1B-44FF-A083-FF34E164DA89Q30238895-D1517BB6-6373-4E65-A274-BD4AE55B8C27Q30279247-CA1F1928-2CDF-4BEB-8179-EA11F29F9FE2Q30403670-FCC9BA82-5865-4515-A2E9-4CEAAB1B2143Q30585821-4ACD83B1-9D72-436C-BF00-C4057BBD7603Q33605089-6E813D35-B1C5-4847-9E6C-72B2CAD12215Q33808159-AEF87A77-E18E-44CC-9261-2A22D5666EEBQ34065560-E0804028-30D9-46AA-8DEB-8CAD1F840C7CQ34079007-971B153A-3EEB-4CD0-B5FF-F868D34D017DQ34464043-AE7AF76E-D375-4A0C-A97C-1426BDBBFBD7Q34656747-0FE3871F-102E-4B1C-A912-B69512568C88Q34763466-52ED2399-E501-4AA8-85F9-706B24F9E07FQ34909875-9600B538-78F9-41FF-ADD8-FD8A74F246F6Q35093239-3DCF3890-8A08-4654-9645-48CD4D15FA1BQ35124985-B3911138-EF94-4C08-B167-B5DBC9F23960Q35693985-14EE3F8C-04E5-4875-B979-A370FB56133FQ35811132-07A7AB98-2B01-436D-A6AD-7F659800CF8EQ35913384-0FE87BBA-6E2C-4C8D-8D81-776A16932C48Q35919809-94578CC0-90D0-48B6-AD9C-854F4740CB6EQ35942610-BECAE2B6-BA32-4CA4-9506-DDB38C47A8D2Q36000994-28B09F39-AC98-4848-890E-50CF217FEB9FQ36009443-07F037FA-684A-4030-A9C9-9EF3893A87E2Q36046443-287D5A75-9435-48A9-ADB7-74A2678AAA2FQ36310498-234FF671-CC41-478C-B7CD-476BB8B2D58EQ36962011-F53D5B9F-E9BB-488A-B69A-68F7483B8ACDQ37621790-03403014-F13C-4E50-B36E-757AA230D47EQ37719383-D0F6E989-7728-4DA8-AC61-CA1DFB8F36FFQ38103214-DAE7CBBD-1B94-4E27-8D81-7D4F4893E4ABQ38116396-87188C8B-0BC7-4E56-A9BD-5BDCF6C9AE6DQ38186132-2EE2BEF8-5B1A-478E-B7C2-89415F9108FEQ38235122-C4083F13-0DCB-4DD4-8D1F-9E3AB9122E24Q38244965-BCFF1FBE-F76D-4233-853D-CA3D0DF4D060Q38245994-FB468F35-FB8A-4A0F-B198-E281B6CFCA62Q38269945-0D12C442-61E2-41D2-9183-447B07437790Q38354294-FF48B477-F2CB-458A-A0B8-048C04B8FF64Q38597008-6CCFC9F7-5E20-4D2E-A35B-0C0B25509C58
P2860
Classification, diagnosis, and management of cholangiocarcinoma
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Classification, diagnosis, and management of cholangiocarcinoma
@ast
Classification, diagnosis, and management of cholangiocarcinoma
@en
Classification, diagnosis, and management of cholangiocarcinoma
@nl
type
label
Classification, diagnosis, and management of cholangiocarcinoma
@ast
Classification, diagnosis, and management of cholangiocarcinoma
@en
Classification, diagnosis, and management of cholangiocarcinoma
@nl
prefLabel
Classification, diagnosis, and management of cholangiocarcinoma
@ast
Classification, diagnosis, and management of cholangiocarcinoma
@en
Classification, diagnosis, and management of cholangiocarcinoma
@nl
P2860
P3181
P1476
Classification, diagnosis, and management of cholangiocarcinoma
@en
P2093
Nataliya Razumilava
P2860
P304
13-21.e1; quiz e3-4
P3181
P356
10.1016/J.CGH.2012.09.009
P407
P577
2013-01-01T00:00:00Z